Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Accumulated Expenses (2016 - 2026)

Exicure's (XCUR) quarterly Accumulated Expenses came in at $2.0 million in Q1 2026, down 24.79% YoY from $2.7 million in Q1 2025, and down 8.33% on a QoQ basis from $2.2 million in Q4 2025.

Exicure (XCUR) Accumulated Expenses (2016 - 2026) Analysis & Trends

Exicure (XCUR) has 11 years of Accumulated Expenses data on file, last reported at $2.0 million in Q1 2026.

  • Quarterly Accumulated Expenses fell 24.79% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 24.79% YoY) and the FY2025 annual result came in at $2.2 million, up 7.75% from the prior year.
  • Accumulated Expenses slipped to $2.0 million in Q1 2026, from $2.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.3 million in Q2 2022 to a low of $836000.0 in Q1 2024.
  • A 5-year average of $1.9 million and a median of $2.0 million in 2026 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 80.23% — and 2025, when it jumped 222.81%.
  • Tracing XCUR's Accumulated Expenses over 5 years: stood at $1.3 million in 2022, then plunged by 31.22% to $879000.0 in 2023, then soared by 132.08% to $2.0 million in 2024, then advanced by 7.75% to $2.2 million in 2025, then decreased by 8.33% to $2.0 million in 2026.
  • The last three Accumulated Expenses figures came in at $2.0 million (Q1 2026), $2.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Exicure 7.27 Mn 7.27 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.02 Mn
Dec 31, 2025 2.20 Mn
Sep 30, 2025 1.46 Mn
Jun 30, 2025 2.73 Mn
Mar 31, 2025 2.68 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 2.32 Mn
Jun 30, 2024 846,000.00
Mar 31, 2024 836,000.00
Dec 31, 2023 879,000.00
Sep 30, 2023 1.36 Mn
Jun 30, 2023 1.09 Mn
Mar 31, 2023 1.48 Mn
Dec 31, 2022 1.28 Mn
Sep 30, 2022 3.02 Mn
Jun 30, 2022 3.31 Mn
Mar 31, 2022 3.23 Mn
Dec 31, 2021 6.46 Mn
Sep 30, 2021 5.48 Mn
Jun 30, 2021 3.23 Mn